Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @justin_klee
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @justin_klee
-
Justin Klee proslijedio/la je Tweet
Welcome to the team as Amylyx' CFO, Jeff Trigilio! Jeff's leadership and financial acumen will be essential as we continue our mission to develop new treatments for
#ALS and#Alzheimer's disease and bring them to patients and families as rapidly as we can. https://bwnews.pr/2tssHym pic.twitter.com/UIWR0wP2aQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Honored to be among
@BosBizJournal drug makers to watch. Here’s to making 2020 a transformative year for those impacted by neurodegenerative diseases#ALS#Alzheimersdisease https://www.bizjournals.com/boston/news/2019/12/26/as-2019-closes-out-these-are-the-local-drugs-and.html?ana=e_mc_prem&j=90421661&t=Niche&mkt_tok=eyJpIjoiTkRFM1lqazRNakU1TXprMCIsInQiOiJJMlpyRkhlMTZmcDZJYlRzcXJoTWhkamUrSENFUXhFaytlOGdcLytpQzZDYVZiK2ZFclhtRHpJblFscHJVNjE5cTNyOG80RGlHNmVJanZcL0RjTGhJeEUxa2NxSDM2ZWk3WUE2bkltdStsWUpSMnYwSXFcL00yV3ZxMTUwZFl2bkNuQiJ9#g/465220/12 …pic.twitter.com/XEwCcftMeB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
A very nice obituary about a best friend and colleague, Dr. Rob Moir, who first joined my lab in 1993 at Mass General Hospital, and changed the way we think about Alzheimer's disease. Thank you
@GinaKolata for a wonderful tribute to Rob.https://nyti.ms/35MPiDKHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Remembering a best friend and brilliant colleague, Dr Rob Moir. Deepest condolences to his family and to the many friends who love him. And, thank you, Sharon for this tribute
@sxbegle Unorthodox Alzheimer’s researcher Robert Moir dies at age 58 https://www.statnews.com/2019/12/20/robert-moir-unorthodox-alzheimers-researcher-dies-at-58 …@statnewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
And thank you
@PaganoniMDPhD for your incredible leadership, passion, and relentless pursuit of new treatments and improvements in care for people with#ALShttps://twitter.com/PaganoniMDPhD/status/1206959265862172672 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
An experimental drug slowed the paralyzing march of Lou Gehrig’s disease in a clinical trial, according to researchers who say the results are a fresh sign that recent insights into the condition may soon bring new medicines.https://www.wsj.com/articles/als-drug-works-in-study-researchers-say-11576558801 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you so much for believing in us from the very start, and for all of your support over so many years!! Thrilled to have the opportunity to help people with ALS and so excited for the potential in Alzheimer's!
@CureAlzheimers@TheADDF@alzassociationhttps://twitter.com/RudyTanzi/status/1206943332221571073 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Long live the bond of the fraternity brothers of
@SigmaChi as we worked together to make this happen and hopefully help ALS patients! Alzheimers's up next!@CureAlzheimershttps://twitter.com/justin_klee/status/1206943910624411650 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you so much to everyone who has made this possible, especially the patients and families battling ALS every day - this is just the start, and we will continue to work tirelessly to advance treatments and care for ALShttps://twitter.com/AmylyxPharma/status/1206937665150558210 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you very much for sharing our story! We're so thankful to everyone who has supported us on this journey, and so hopeful for what's to comehttps://twitter.com/jonathanrockoff/status/1206908182595035136 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Deb is a phenomenal HR executive and we're so proud to have her join us. Her leadership will be a huge asset as we continue to build and grow, while always keeping focused on our missionhttps://twitter.com/AmylyxPharma/status/1205514960597590016 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
In a recent interview with
@PracticalNeurol, cofounder@justin_klee and@CentaurStudy PI@PaganoniMDPhD discussed Amylyx' mission to do right by patients if this trial is a success and the impact of a partnership between industry and academia. Read more:http://bit.ly/36bj05UHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Congratulations to
@CentaurStudy Principal Investigator@PaganoniMDPhD on this incredible recognition for all of your efforts in the#ALS community.#AANEMhttps://twitter.com/MGHNeurology/status/1184465738335019011 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
We’re thrilled to announce the last
@CentaurStudy participant has completed the planned 24 weeks of study treatment. "Thank you to the participants and site study teams who have made this work possible,” said Principle Investigator,@PaganoniMDPhD.#ALShttps://bwnews.pr/2VfKW3nHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Today at
#NEALS19, Principal Investigator of@CentaurStudy,@PaganoniMDPhD, presented the novel features and design of the#ALS clinical trial. We’re proud to share nearly 90% of participants have elected to continue into the open label extension#NeurodegenerativeDiseasespic.twitter.com/nepUFwSNSx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
#NEALS19 lessons from CENTAUR trial (@AmylyxPharma): - Central IRB feasible - Loud and clear: pts value access to open label extension (OLE) after trial completion - OLE is feasible, adds value w/long term safety data for FDA@PaganoniMDPhD@justin_klee@JoshuaBCohen1Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
We are encouraged by the new FDA guidance on
#ALS – particularly that all trials should have open label extensions and not exclude standard of care. Exciting to see the FDA innovating on more patient-centric trials.https://www.fda.gov/news-events/press-announcements/statement-final-guidance-help-advance-development-novel-treatments-als?utm_campaign=092319_Statement_FDA%20issues%20guidance%20to%20help%20development%20of%20novel%20treatments%20for%20ALS&utm_medium=email&utm_source=Eloqua …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
Heading to
#POMfg19 next week in#Philadelphia? Tom Holmes, Amylyx’ global head of supply chain and keynote speaker, will be sharing his insights on the reliability and security of internal and external supply chains. Hope to see you there!#pharma#outsourcingpic.twitter.com/T4oXJ2484o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
@Louis_Garguilo thank you again for an excellent interview and article on Amylyx's goals to help patients with neurodegenerative diseases, and how integral outsourcing is to achieving those goalshttps://twitter.com/Louis_Garguilo/status/1153268658359156736 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Justin Klee proslijedio/la je Tweet
ICYMI: Dr. Emily Plowman, one of our Clinical Management Grant awardees, & her colleague, Dr. James Wymer, found that a mild-intensity respiratory strength training program was safe & improved function in a person with early-stage
#ALS. http://bit.ly/2Rj87Yg#MND#ALSResearchpic.twitter.com/CH1W0stw4w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.